Article
Using betaxolol for the prevention of paronychia induced by epidermal growth factor receptor inhibitors: a case-control cohort study.
International journal of dermatology - 1 Feb 2021
Lu Chun-Wei, Wang Ting-Ya, Yen Chi-Feng, Chen Kang-Hua, Wu Chiao-En, Wang Chih-Liang, Hsu Ping-Chih, Fang Yueh-Fu, Li Shih-Hong, Ko How-Wen, Tseng Li-Chuan, Shih Feng-Ya, Lin Yu-Jr, Chen Mei-Jun, Chen Chun-Bing, Su Pang Jong-Hwei, Chung Wen-Hung, Ko Yu-Shien
Abstract excerpt
BACKGROUND: High rates of posttreatment discomfort, infection, recurrence, and increased time to return to work have been noted after nail plate avulsion resulting from epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)-induced paronychia, which may even interrupt the course of treatment for EGFR-TKI therapy. Thus, we conducted this study to determine how effectively a topical β-blocker,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.